EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Retrorectal epidermoid cyst with unusually elevated serum SCC level, initially diagnosed as an ovarian tumor

Masaru Hayashi, Shigeki Tomita, Takahiro Fujimori, Hitoshi Nagata, Keiichi Kubota, Akiko Shoda, Kazumi Tada, Nobuaki Kosaka, Ichio Fukasawa, Noriyuki Inaba

Rare Tumors · 2009

DOI: 10.4081/rt.2009.e21 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Rare Tumors, 2009. Verfasst von Masaru Hayashi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Dokkyo Medical University, Mibu, Tochigi, Japan;. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

SCC-antigendevelopmental cystsovarian tumor.retrorectal epidermoid cystserum SCC

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Dokkyo Medical University, Mibu, Tochigi, Japan;

Zitieren

APA

Hayashi, M., Tomita, S., Fujimori, T., Nagata, H., Kubota, K., Shoda, A., Tada, K., Kosaka, N., Fukasawa, I., & Inaba, N. (2009). Retrorectal epidermoid cyst with unusually elevated serum SCC level, initially diagnosed as an ovarian tumor. Rare Tumors. https://doi.org/10.4081/rt.2009.e21

Vancouver

Hayashi M, Tomita S, Fujimori T, Nagata H, Kubota K, Shoda A, et al. Retrorectal epidermoid cyst with unusually elevated serum SCC level, initially diagnosed as an ovarian tumor. Rare Tumors. 2009. doi:10.4081/rt.2009.e21

BibTeX
@article{Hayashi2009,
  author = {Hayashi, Masaru and Tomita, Shigeki and Fujimori, Takahiro and Nagata, Hitoshi and Kubota, Keiichi and Shoda, Akiko and Tada, Kazumi and Kosaka, Nobuaki and Fukasawa, Ichio and Inaba, Noriyuki},
  title = {Retrorectal epidermoid cyst with unusually elevated serum SCC level, initially diagnosed as an ovarian tumor},
  journal = {Rare Tumors},
  year = {2009},
  doi = {10.4081/rt.2009.e21}
}
Kostenlos starten →